Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »
Reset 

Dermavant to Present at JMP Securities Life Science Conference

BASEL, Switzerland, June 19, 2018 /PRNewswire/ -- Dermavant today announced that President and Chief Operating Officer Vince Ippolito will present a corporate overview at the JMP Securities Life Science Conference on June 20, 2018 at 2:00 p.m. ET.

Read more ››
By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  Dermavant Sciences GmbH

Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity and development of innovative technologies

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jun 2018
Related companies:  Esperite N.V. | Esperite (Life Sciences)

Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jun 2018
Related companies:  Sanofi

Shire plc: Rule 2.9 Announcement

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jun 2018

Constitutive meeting of Biohit Oyj’s Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jun 2018
Related companies:  BIOHIT OYJ

C-RAD publishes outcome of Employee Warrant Program 2018/2021

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jun 2018

Speakeasy Looks to Expand into German Market -- CFN Media

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jun 2018

Novo Nordisk A/S - Share repurchase programme

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jun 2018
Related companies:  Novo Nordisk A/S | The Novo Nordisk Foundation Center for Biosustainability

Transactions in relation to share buyback program

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jun 2018

Genetic Technologies Announces Heads of Agreement with Swisstec

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jun 2018
Related companies:  Applied Genetic Technologies Corp. (AGTC) | Genetic Technologies Limited

Amphastar Announces Approval for Isoproterenol Hydrochloride Injection, USP

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jun 2018
Related companies:  Amphastar Pharmaceuticals, Inc.

U.S. Healthcare Leader Joseph R. Swedish Joins Mesoblast Board

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jun 2018
Related companies:  MESOBLAST LTD | Mesoblast, Inc.

Targovax Granted EU Patent for Mutant-RAS Neoantigen Platform 2nd Generation Product TG02

OSLO, Norway, June 19, 2018 /PRNewswire/ -- Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), is a clinical stage company focused on developing and commercializing immune activators to target hard to treat solid tumors, announces that the European Patent Office has granted European Patent... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  Targovax ASA

Alpha Biopharma Announces Series A Financing

SHANGHAI, June 19, 2018 /PRNewswire/ -- Alpha Biopharma Inc. ("AlphaBio") today announced the first $37M closing of its $65M Series A financing led by Qiming Venture Partners, one of the most prominent venture capital firms in China. Other notable investors that participated in the round included... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018

Teva Pharmaceuticals Honored with Klaus Tschira Human Resources Innovation Award

BERLIN, Germany, June 19, 2018 /PRNewswire/ -- SAP SE (NYSE: SAP) today announced Teva Pharmaceutical Industries Ltd. as the 2018 recipient of the Klaus Tschira Human Resources Innovation Award... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  SAP SE

Invictus Signs LOI For Cannabis Sales Into Germany

VANCOUVER, British Columbia, June 19, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Jun 2018

Kazia Releases Preliminary Cantrixil Phase I Data

SYDNEY, June 19, 2018 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to provide an interim update to shareholders regarding its phase I clinical trial of Cantrixil (TRX-E-002-1) in relapsed or recurrent ovarian... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018

Portuguese Hospital Expands its VNA From Sectra With Digital Pathology to Improve Cancer Care

LINKÖPING, Sweden, June 19, 2018 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a digital pathology contract with Instituto Português de Oncologia de Lisboa... Read more ››

By: PR Newswire Association LLC. - 19 Jun 2018
Related companies:  Sectra AB

Water.io's Internet of Packaging Service Earns It Frost & Sullivan's Prestigious Entrepreneurial Company of the Year Award

Water.io's platform turns CPG products into smart products that can provide valuable data for both the consumer and the brand

Read more ››
By: PR Newswire Association LLC. - 19 Jun 2018

Robotics: Changing the Face of Drug Discovery - PharmaBoardroom

LONDON, June 19, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Jun 2018
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »
to the top ↑